LU87331A1 - Orale magnesium und kalium enthaltende praeparate und deren verwendung - Google Patents

Orale magnesium und kalium enthaltende praeparate und deren verwendung Download PDF

Info

Publication number
LU87331A1
LU87331A1 LU87331A LU87331A LU87331A1 LU 87331 A1 LU87331 A1 LU 87331A1 LU 87331 A LU87331 A LU 87331A LU 87331 A LU87331 A LU 87331A LU 87331 A1 LU87331 A1 LU 87331A1
Authority
LU
Luxembourg
Prior art keywords
potassium
magnesium
pharmaceutical preparations
bioavailable
preparations according
Prior art date
Application number
LU87331A
Other languages
German (de)
English (en)
Inventor
Frederick J Dechow
Pravin B Dr Sheth
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of LU87331A1 publication Critical patent/LU87331A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LU87331A 1987-09-11 1988-09-07 Orale magnesium und kalium enthaltende praeparate und deren verwendung LU87331A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9575087A 1987-09-11 1987-09-11
US9575087 1987-09-11

Publications (1)

Publication Number Publication Date
LU87331A1 true LU87331A1 (fr) 1989-10-26

Family

ID=22253423

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87331A LU87331A1 (fr) 1987-09-11 1988-09-07 Orale magnesium und kalium enthaltende praeparate und deren verwendung

Country Status (12)

Country Link
JP (1) JPH01100128A (fr)
AU (1) AU619481B2 (fr)
BE (1) BE1001842A3 (fr)
CH (1) CH677612A5 (fr)
DE (1) DE3830563A1 (fr)
DK (1) DK501288A (fr)
FR (1) FR2620334A1 (fr)
GB (1) GB2209668B (fr)
IT (1) IT1227010B (fr)
LU (1) LU87331A1 (fr)
NL (1) NL8802224A (fr)
SE (1) SE8803125L (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015611A1 (fr) * 1989-06-20 1990-12-27 Otsuka Pharmaceutical Co., Ltd. Composition d'apport de potassium
US5132118A (en) * 1990-05-11 1992-07-21 Mills John A Treatment of exercise-induced pulmonary hemorrhage in animals
FI911038A (fi) * 1991-03-01 1992-09-02 Slk Marketing Oy Dryckpulver.
US5460972A (en) * 1991-04-08 1995-10-24 Research Foundation Of The State University Of New York Ionized magnesium2+ concentrations in biological samples
FR2677546B1 (fr) * 1991-06-12 1994-01-21 Fabienne Joanny Composition therapeutique pour liberation prolonge de magnesium.
DE4201504C2 (de) * 1992-01-21 1997-04-30 Protina Chemische Ges Mbh Magnesiumpräparat
CN1090483C (zh) * 1997-07-31 2002-09-11 谢理峰 钾镁缓释片及生产方法
DE10158286B4 (de) * 2000-11-20 2007-08-02 Dehn, Michael C. Wirkstoffspeicherndes Schichtmaterial
DE10126405A1 (de) * 2001-05-22 2003-02-27 Trommsdorff Gmbh & Co Physiologisch verträgliche Kalium- und Magnesiumsalze enthaltendes pharmazeutisches Präparat sowie dessen Verwendung zur Prophylaxe und/oder Therapie von QT-Zeitverlängerungen
ATE485814T1 (de) * 2005-08-19 2010-11-15 Verla Pharm Magnesium-mikrotabletten mit verzögerter freisetzung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA73467B (en) * 1972-02-25 1973-10-31 Hoffmann La Roche Mineral salts containing preparation
GB1422193A (en) * 1974-07-26 1976-01-21 Smith Kline French Lab Pharmaceutical compositions

Also Published As

Publication number Publication date
JPH01100128A (ja) 1989-04-18
GB2209668A (en) 1989-05-24
DK501288A (da) 1989-03-12
GB2209668B (en) 1991-06-05
SE8803125L (sv) 1989-03-12
AU619481B2 (en) 1992-01-30
SE8803125D0 (sv) 1988-09-06
CH677612A5 (fr) 1991-06-14
FR2620334A1 (fr) 1989-03-17
DK501288D0 (da) 1988-09-09
IT1227010B (it) 1991-03-05
GB8821056D0 (en) 1988-10-05
BE1001842A3 (fr) 1990-03-20
IT8848327A0 (it) 1988-09-08
AU2204388A (en) 1989-03-16
DE3830563A1 (de) 1989-03-30
NL8802224A (nl) 1989-04-03

Similar Documents

Publication Publication Date Title
DE69432618T2 (de) Arzneimittel mit gesteuertem Beginn und gesteuerter Rate der Freisetzung
DE60019116T2 (de) Neue omeprazole und (s)-omeprazole zusammensetzung
EP0519870B1 (fr) Nouvelle composition à base de diclofenac pour l'administration orale
EP1183015B1 (fr) Comprime a couches multiples pour l'administration d'une combinaison fixe de tramadol et de diclofenac
EP0032562B1 (fr) Formes-retard pour l'administration du dipyridamol et procédés pour leur préparation
EP0386440B1 (fr) Médicament à libération contrôlée
AT398166B (de) Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen)
DE3822095A1 (de) Neue arzneimittelformulierung sowie verfahren zu deren herstellung
DD273197A5 (de) Verfahren zur herstellung eines omeprazol enthaltenden oralen pharmazeutischen praeparates
DE3024858A1 (de) Anhaltend freigebende pharmazeutische zubereitung eines festen medikamentmaterials
DE2551280A1 (de) L-dopa-zubereitung
DD202505A5 (de) Neue orale dipyridamolformen
DD266734A5 (de) Verfahren zur herstellung von kaernern mit gesteuerter wirkstoffabgabe
DD298205A5 (de) Verfahren zum herstellen von langzeitwirkenden arzneimittelzubereitungen
DE1617374A1 (de) Verfahren zum Herstellen eines pharmazeutischen Praeparates mit verzoegerter Wirkung
CH678813A5 (fr)
EP0128483A2 (fr) Formes galéniques d'antidiabétiques orales et procédé de leur préparation
EP0250648B1 (fr) Préparation pharmaceutique pour la libération retardée de l'ibuprofène
EP2155172A2 (fr) Système de rétention gastrique renfermant un corps d'alginate
DE3856555T2 (de) Diltiazem-Zusammensetzungen mit kontrollierter Wirkstoffabsorption
US4954349A (en) Oral magnesium and potassium compositions and use
LU87331A1 (fr) Orale magnesium und kalium enthaltende praeparate und deren verwendung
EP1315481A1 (fr) Medicament pour le traitement de maladies intestinales
DE3404595A1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe
DE2721785A1 (de) Oral verabfolgbares cephalexinpraeparat mit verzoegerter wirkstoffabgabe